113P Comparative efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or in addition to chemotherapy for advanced, PD-L1 high non-small cell lung cancer (NSCLC): A meta-analysis of randomized trials

A. Di Federico, A. De Giglio, G. Nuvola, C. Deiana, N. Conci, C. Bonucci, G. Donati, C. Parisi, F. Gelsomino,A. Ardizzoni

Journal of Thoracic Oncology（2021）

引用 0|浏览0